Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Tripeptides – e.g. – tripeptide thyroliberin – etc.
Patent
1995-05-17
2000-01-18
Tsang, Cecilia J.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Tripeptides, e.g., tripeptide thyroliberin , etc.
514 18, 514 19, A61K 3806
Patent
active
060158794
ABSTRACT:
Methods of use of compounds and compounds for the treatment of disorders characterized by the cerebral deposition of amyloid are provided Among the compounds are those of formulae I and II: ##STR1## in which R.sub.1 is preferably 2-methyl propene, 2-butene, cyclohexyl or cyclohexylmethyl; R.sub.2, R.sub.4, and R.sub.8 are each independently methyl or ethyl; R.sub.3 is preferably iso-butyl or phenyl; R.sub.5 is preferably iso-butyl; R.sub.6 is H or methyl; R.sub.7 --(Q).sub.n is preferably benzyloxycarbonyl or acetyl; Q is preferably --C(O)--; R.sub.B is preferbly iso-butyl; --R.sub.A =--(T).sub.m --(D).sub.m --R.sub.1, is which T is preferably oxygen or carbon, and D is preferably a mono-unsaturated C.sub.3-4 alkenyl being more preferred; and X is preferably an .alpha.-ketoester or .alpha.-ketoamide or aldehyde.
REFERENCES:
patent: 4044126 (1977-08-01), Cook et al.
patent: 4364923 (1982-12-01), Cook et al.
patent: 4414209 (1983-11-01), Cook et al.
patent: 4472305 (1984-09-01), Hansen et al.
patent: 4666829 (1987-05-01), Glenner et al.
patent: 4701407 (1987-10-01), Appel
patent: 4840935 (1989-06-01), Wagnon et al.
patent: 4845079 (1989-07-01), Luly et al.
patent: 5015570 (1991-05-01), Scangos et al.
patent: 5034376 (1991-07-01), Hoover
patent: 5039511 (1991-08-01), Quay et al.
patent: 5039642 (1991-08-01), Chrobaczek et al.
patent: 5081284 (1992-01-01), Higuchi et al.
patent: 5164371 (1992-11-01), Edwards et al.
patent: 5200339 (1993-04-01), Abraham
patent: 5213962 (1993-05-01), van Nostrandt et al.
patent: 5218100 (1993-06-01), Muller-Hill et al.
patent: 5221665 (1993-06-01), Skiles
patent: 5223633 (1993-06-01), Hoppe et al.
patent: 5231000 (1993-07-01), Majocha et al.
patent: 5232928 (1993-08-01), Skiles
patent: 5234814 (1993-08-01), Card et al.
patent: 5242932 (1993-09-01), Gandy et al.
patent: 5270165 (1993-12-01), van Nostrandt et al.
patent: 5284828 (1994-02-01), Hemmi et al.
patent: 5374623 (1994-12-01), Zimmerman et al.
patent: 5427931 (1995-06-01), Van Nostrand et al.
patent: 5430022 (1995-07-01), Hemmi et al.
patent: 5436229 (1995-07-01), Ruterbories
patent: 5441870 (1995-08-01), Seubert et al.
patent: 5470833 (1995-11-01), Ishikawa et al.
patent: 5496928 (1996-03-01), Ishikawa et al.
patent: 5508167 (1996-04-01), Roses et al.
patent: 5538845 (1996-07-01), Knops et al.
patent: 5547841 (1996-08-01), Marrotta et al.
patent: 5593846 (1997-01-01), Schenk et al.
patent: 5604102 (1997-02-01), McConlogue et al.
patent: 5605811 (1997-02-01), Seubert et al.
patent: 5612486 (1997-03-01), McConlogue et al.
Higgins, et al., "Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for .beta.-APP751," Proc. Natl. Acad. Sci. USA, 92:4402-4406 (1995).
Mahdi et al., "Protease nexin/amyloid .beta.-protein precursor inhibits factor Xa in the prothrombinase complex," J. Biol. Chem. 270(40):23468-23474 (1995).
Moss et al., "Peptidometric inhibitors of herpes simplex virus ribonucleotide reductase: A new class of antiviral agents," J. Med. Chem. 38:3617-3623 (1995).
Pike et al., "Amino-terminal deletions enhance aggregation of .beta.-amyloid peptides in vitro," J. Biol. Chem. 270(41):23895-23898 (1995).
Thaisrivongs et al., "Structure-based design of novel HIV protease inhibitors: Carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors," J. Med. Chem. 38:3624-3637 (1995).
Wang et al., "A novel matrix attachment region DNA binding motif identified using a random phage peptide library," J. Biol. Chem. 270(40):23239-23242 (1995).
Xu et al., "Regulated formation of Golgi secretory vesicles containing Alzheimer's .beta.-amyloid precursor protein," J. Biol. Chem. 270(40):23243-23245 (1995).
Yoshimoto et al., "NACP, the precursor protein of the non-amyloid .beta./A4 protein (A.beta.) component of Alzheimer's disease amyloid, binds A.beta. and stimulates A.beta. aggregation," Proc. Natl. Acad. Sci. USA 92:9141-9145 (1995).
Ito, 186081c Preparation of N-benzyloxycarbonyl tripeptide aldehydes for treatment of senile dementia, Chem. Abstr. 114(19):850 (1991).
Klafki et al., Calpain inhibitor I decreases .beta.A4 secretion from human embryonal kidney cells expressing .beta.-amyloid precursor protein carrying the APP670/671 double mutation, Neurosci. Lttrs 201:29-32 (1995).
Sarubbi et al., Peptide aldehydes as inhibitors of HIV protease, FEBS Lttrs 319(3):253-256, (1993).
Sasaki et al., Inhibitory effect of di-and tripeptidy 1 aldehydes on calpains and cathepsins, J. Enzyme Inhibition 3(3):195-200, (1990).
Anderson et al., "Differential induction of immediate early gene proteins in cultured neurons by .beta.-amyloid (A.beta.): Association of c-jun with A.beta.-induced apoptosis," J. Neurochem. 65(4):1487-1498 (1995).
Asami-Odaka et al., "Long amyloid .beta.-protein secreted from wild-type human neuroblastoma IMR-32 cells," Biochemistry 34:10272-10278 (1995).
Barry et al., "Protection against mycoplasma infection using expression-library immunization," Nature 377:632-635 (1995).
Checler, "Processing of the .beta.-amyloid precursor protein and its regulation in Alzheimer's disease," J. Neurochem. 65(4):1431-1444 (1995).
Lannfelt et al., "Decreased cerebrospinal fluid .alpha.-secretase cleaved amyloid precursor protein (APP) separates Alzheimer patients with the Swedish APP.sub.670/671 mutation from non-mutation carriers," Soc. Neurosci. Abstr. 21 (1995).
Le et al, ".beta.-amyloid.sub.1-40 increases expression of .beta.-amyloid precursor protein in neuronal hybrid cells," J. Neurochem. 65(5):2373-2376 (1995).
Angelastro, et al., "Inhibition of Human Neutrophil Elastase with Peptidyl Electrophilic Ketones," J. Med. Chem., 37:4538-4554 (1994).
Angliker, et al., "Inactivation of calpain by peptidyl fluoromethyl ketones," J. Med. Chem., 35:216-220 (1992).
Arneer, et al., "1-Chloro-2,4-dinitrobenzene is an Irreversible Inhibitor of Human Thioredoxin Reductase," J. Biol. Chem. 270(8):3479-3482 (1995).
Bodansky and Bodansky, "I. Protecting Groups 5. The tert.Butyloxycarbonyl (Boc) Group," The Practice of Peptides Synthesis, Springer-Verlag, pp. 18-20 (1984).
Bradbury, et al., "1,2,4-Triazolo[4,3-.alpha.]pyrazine Derivatives with Human Renin Inhibitory Activity," J. Med. Chem., 33:2335-2342 (1990).
Breaux and Bender, "The binding of specific and non-specific aldehyde substrate analogs to .alpha.-chymotrypsin," FEBS Letters, 56(1):81-84 (1975).
Buxbaum, et al., "Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer .beta./1A4 amyloid protein precursor," Proc. Natl. Acad. Sci. USA, 89:10075-10078 (1992).
Cai, et al., "Release of excess amyloid .beta. protein from a mutant amyloid .beta. protein precursor," Science, 259:514-516 (1993).
Caporaso, et al., "Chloroquine inhibits intracellular degradation but not secretion of Alzheimer .beta./1A4 amyloid precursor protein," Proc. Natl. Acad. Sci. USA, 89:2252-2256 (1992).
Citron, et al., "Mutation of the .beta.-amyloid precursor protein in familial Alzheimer's disease increases .beta.-protein production," Nature, 360:672-674 (1992).
Cooper, et al., "X-ray Crystallographic Analysis of Inhibition of Endothiapepsin by Cyclohexyl Renin Inhibitors," Biochemistry, 31:8142-8150 (1992).
Cooper, et al., "X-ray Studies of Aspartic Proteinase-Statine Inhibitor Complexes," Biochemistry, 28:8596-8603 (1989).
Crawford, et al., "The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B," J. Biochem., 253:751-758 (1988).
Crawford, "Protein and peptide inhibitors of calpains," Intracellular Calcium-Dependent Proteolysis, Chapter 5, pp. 75-89.
Davis, et al., "A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease," New England J. of Med., 327(18):1253-1259 (1992).
De Strooper, et al., "Basolateral Secretion of Amyloid Precursor Protein in a Madin-Darby Canine Kidney Cells is Disturbed by Alterations of Intracellular pH and by Introducing a Mutation Associated with Familial Alzheimer's Disease," J. Biol. Chem. 270(8):4058-4065 (1995).
Dess and Martin, "Readily acces
Albrecht Elisabeth
McDonald Ian Alexander
Munoz Benito
Lukton David
Seidman Stephanie L.
SIBIA Neurosciences Inc.
Tsang Cecilia J.
LandOfFree
Peptide and peptide analog protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide and peptide analog protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide and peptide analog protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-564132